Efficacy of night-time compression for breast cancer related lymphedema (LYNC): Protocol for a multi-centre, randomized controlled efficacy trial

BMC Cancer

Volumn 16, Issue 1, 2016, Pages

  McNeely, Margaret L ^a   Campbell, Kristin L ^b   Webster, Marc ^c   Kuusk, Urve ^d   Tracey, Karen ^e   Mackey, John ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e CROSS CANCER INSTITUTE   (Canada)

Author keywords

Breast cancer; Compression therapy; Lymphedema; Physical therapy

Indexed keywords

ARTICLE; BREAST CANCER; CANADA; CANCER SURVIVOR; CLINICAL EFFECTIVENESS; COMPRESSION BANDAGE; COMPRESSION GARMENT; COMPRESSION THERAPY; HUMAN; LYMPHEDEMA; NIGHT TIME COMPRESSION; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; TREATMENT RESPONSE; BREAST CANCER LYMPHEDEMA; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; METHODOLOGY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

BREAST CANCER LYMPHEDEMA; COMPRESSION BANDAGES; FEMALE; HUMANS; RESEARCH DESIGN;

EID: 84982696430     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-2648-8     Document Type: Article

References (22)

1. Canadian Cancer Statistics; 2015. https://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/Canadian-Cancer-Statistics-2015-EN.pdf. Accessed 1 Oct 2015.
2. Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999;177(3):184-8.
3. DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500-15.
4. Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott JM. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2007;16(4):775-82.
5. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26(21):3536-42.
6. Campbell KL, Pusic AL, Zucker DS, McNeely ML, Binkley JM, Cheville AL, Harwood KJ. A prospective model of care for breast cancer rehabilitation: function. Cancer. 2012;118(8 Suppl):2300-11.
7. Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol. 2012;30(30):3726-33.
8. Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27(12):2007-14.
9. Framework L. Best practice for the management of lymphoedema: an international consensus. London: MEP Ltd; 2006. London: MEP Ltd; 2006.
10. Armer JM. Lymphedema. In: Hassey Dow K, editor. Nursing Care of Women with Cancer. St. Louis: Mosby Elsevier; 2006. p. 204-25.
11. Chang CJ, Cormier JN. Lymphedema interventions: exercise, surgery, and compression devices. Semin Oncol Nurs. 2013;29(1):28-40.
12. Lasinski BB, McKillip Thrift K, Squire D, Austin MK, Smith KM, Wanchai A, Green JM, Stewart BR, Cormier JN, Armer JM. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM R. 2012;4(8):580-601.
13. Vignes S, Porcher R, Arrault M, Dupuy A. Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy. Support Care Cancer. 2011;19(7):935-40.
14. International Society of Lymphology. Consensus document of the International Society of Lymphology. Lymphology. 2003;36(2):84-91.
15. Harris SR, Hugi MR, Olivotto IA, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ. 2001;164(2):191-9.
16. Stanton AW, Northfield JW, Holroyd B, Mortimer PS, Levick JR. Validation of an optoelectronic limb volumeter (Perometer). Lymphology. 1997;30(2):77-97.
17. Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol. 2005;3(4):208-17.
18. Ancukiewicz M, Russell TA, Otoole J, Specht M, Singer M, Kelada A, Murphy CD, Pogachar J, Gioioso V, Patel M, et al. Standardized method for quantification of developing lymphedema in patients treated for breast cancer. Int J Radiat Oncol Biol Phys. 2011;79(5):1436-43.
19. Devoogdt N, Van Kampen M, Geraerts I, Coremans T, Christiaens MR. Lymphoedema Functioning, Disability and Health questionnaire (Lymph-ICF): reliability and validity. Phys Ther. 2011;91(6):944-57.
20. Ward LC, Czerniec S, Kilbreath SL. Quantitative bioimpedance spectroscopy for the assessment of lymphoedema. Breast Cancer Res Treat. 2009;117(3):541-7.
21. Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med. 2005;6(1):41-4.
22. Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001;4(6):256-62.